Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Parnes

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Blood|December 15, 2005
Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cellsAukje W Zimmerman, Ben Joosten, Ruurd Torensma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1993
CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursorM M Landolfi, N Van Houten, J Q Russell, et al.
European Journal of Immunology|October 1, 1995
Human CD6 possesses a large, alternatively spliced cytoplasmic domainW H Robinson, H E Neuman de Vegvar, S S Prohaska, et al.
Immunogenetics|January 1, 1996
Chromosomal mapping of the second human CD8B gene locusX L Zhang, H H Heng, Y Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
Distinct stage-specific cis-active transcriptional mechanisms control expression of T cell coreceptor CD8 alpha at double- and single-positive stages of thymic developmentX L Zhang, R Seong, R Piracha, et al.
Journal of Clinical Pharmacology|December 28, 2020
Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab to Guide Phase 3 Dose Selection for Patients With Severe AsthmaNeang Ly, Yanan Zheng, Janet M Griffiths, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 6, 2021
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma and Perennial AllergyJonathan Corren, Christopher S Ambrose, Kinga Sałapa, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1981
Control of expression of histocompatibility antigens (H-2) and beta 2-microglobulin in F9 teratocarcinoma stem cellsC M Croce, A Linnenbach, K Huebner, et al.
Journal of the American Academy of Dermatology|December 15, 2018
Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trialEric L Simpson, Jane R Parnes, Dewei She, et al.
Nature|November 16, 1989
Inability of CD8 alpha' polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivoR Zamoyska, P Derham, S D Gorman, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Blood|December 15, 2005
Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cellsAukje W Zimmerman, Ben Joosten, Ruurd Torensma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1993
CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursorM M Landolfi, N Van Houten, J Q Russell, et al.
European Journal of Immunology|October 1, 1995
Human CD6 possesses a large, alternatively spliced cytoplasmic domainW H Robinson, H E Neuman de Vegvar, S S Prohaska, et al.
Immunogenetics|January 1, 1996
Chromosomal mapping of the second human CD8B gene locusX L Zhang, H H Heng, Y Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
Distinct stage-specific cis-active transcriptional mechanisms control expression of T cell coreceptor CD8 alpha at double- and single-positive stages of thymic developmentX L Zhang, R Seong, R Piracha, et al.
Journal of Clinical Pharmacology|December 28, 2020
Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab to Guide Phase 3 Dose Selection for Patients With Severe AsthmaNeang Ly, Yanan Zheng, Janet M Griffiths, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 6, 2021
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma and Perennial AllergyJonathan Corren, Christopher S Ambrose, Kinga Sałapa, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1981
Control of expression of histocompatibility antigens (H-2) and beta 2-microglobulin in F9 teratocarcinoma stem cellsC M Croce, A Linnenbach, K Huebner, et al.
Journal of the American Academy of Dermatology|December 15, 2018
Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trialEric L Simpson, Jane R Parnes, Dewei She, et al.
Nature|November 16, 1989
Inability of CD8 alpha' polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivoR Zamoyska, P Derham, S D Gorman, et al.
Pageof 13